SENP1-IN-4
SENP1-IN-4 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 21. SENP1-IN-4 is developed for tumor radiosensitivity enhancement[1].
Product Specifications
CAS Number
2416910-64-8
UNSPSC
12352211
Target
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/senp1-in-4.html
Purity
98.0
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CC1(C)[C@@H](O)CC[C@]2(C)[C@@]3([H])CC=C4[C@]5([H])[C@@H](C)[C@H](C)CC[C@@](C(NCC(NC)=O)=O)5CC[C@](C)4[C@@](C)3CC[C@@]12[H]
Molecular Formula
C33H54N2O3
Molecular Weight
526.79
References & Citations
[1]Li, Yiliang, et al. Preparation of ursolic acid derivatives useful as SENP1 inhibitors and tumor radiosensitizer. CN110627860A.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
(2S,3E)-4-Bromo-1-(4-fluorophenoxy)-3-buten-2-ol-d4
![MLF2 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI1G1]](https://cdn.genprice.uk/products/937/6868c367994c49e6dc3f5dd5/imageurl/ta504876am.webp)
MLF2 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI1G1]
